These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis. Bleijerveld OB; Zhang YN; Beldar S; Hoefer IE; Sze SK; Pasterkamp G; de Kleijn DP Proteomics Clin Appl; 2013 Aug; 7(7-8):490-503. PubMed ID: 23670906 [TBL] [Abstract][Full Text] [Related]
11. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?]. Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606 [TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics. Thomas A; Lenglet S; Chaurand P; Deglon J; Mangin P; Mach F; Steffens S; Wolfender JL; Staub C Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412 [TBL] [Abstract][Full Text] [Related]
13. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers. Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734 [TBL] [Abstract][Full Text] [Related]
14. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Martin-Ventura JL; Duran MC; Blanco-Colio LM; Meilhac O; Leclercq A; Michel JB; Jensen ON; Hernandez-Merida S; Tuñón J; Vivanco F; Egido J Circulation; 2004 Oct; 110(15):2216-9. PubMed ID: 15249501 [TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery. Matta A; Ralhan R; DeSouza LV; Siu KW Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361 [TBL] [Abstract][Full Text] [Related]
16. Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK. Blanco-Colio LM; Martín-Ventura JL; Carrero JJ; Yilmaz MI; Moreno JA; Gómez-Guerrero C; Ortiz A; Egido J Proteomics Clin Appl; 2011 Jun; 5(5-6):281-8. PubMed ID: 21538911 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. Arab S; Gramolini AO; Ping P; Kislinger T; Stanley B; van Eyk J; Ouzounian M; MacLennan DH; Emili A; Liu PP J Am Coll Cardiol; 2006 Nov; 48(9):1733-41. PubMed ID: 17084242 [TBL] [Abstract][Full Text] [Related]
18. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis]. Andrié R; Braun P; Welsch U; Straube E; Höpp HW; Erdmann E; Lüderitz B; Bauriedel G Z Kardiol; 2003 Jun; 92(6):455-65. PubMed ID: 12819994 [TBL] [Abstract][Full Text] [Related]
19. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease. Schirmer SH; Fledderus JO; van der Laan AM; van der Pouw-Kraan TC; Moerland PD; Volger OL; Baggen JM; Böhm M; Piek JJ; Horrevoets AJ; van Royen N J Mol Cell Cardiol; 2009 Feb; 46(2):177-85. PubMed ID: 19059264 [TBL] [Abstract][Full Text] [Related]